Yoon, Se-Jung <br/><br/>
Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy.  [electronic resource] 

 -  Experimental & molecular medicine  Nov 2009 
 - 802-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2092-6413 
<br/><br/><label>Standard No.: </label>10.3858/emm.2009.41.11.086  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta--metabolism<br/>Cell Proliferation--drug effects<br/>Cyclooxygenase 2--metabolism<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetic Angiopathies--drug therapy<br/>Glycation End Products, Advanced--metabolism<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Male<br/>Myocytes, Smooth Muscle--metabolism<br/>Oxidative Stress--drug effects<br/>Proto-Oncogene Proteins c-jun--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reactive Oxygen Species--metabolism<br/>Signal Transduction--drug effects<br/>Simvastatin--pharmacology<br/>Transcription Factor RelA--metabolism<br/>p38 Mitogen-Activated Protein Kinases--metabolism